| # | Drug | Count |
|---|---|---|
| 0 | RITONAVIR | 21 |
| 1 | INDOMETHACIN | 18 |
| 2 | ACETAMINOPHEN | 16 |
| 3 | CYTARABINE | 16 |
| 4 | AMPHOTERICIN B | 15 |
| 5 | CEFUROXIME | 14 |
| 6 | MAGNESIUM | 14 |
| 7 | MEROPENEM | 14 |
| 8 | RITONAVIR 100 MG | 14 |
| 9 | ACETAMINOPHEN 500MG | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DINOPROSTONE | 13 | 0.0159 |
| 1 | IBUPROFEN LYSINE | 4 | 0.0070 |
| 2 | BUTALBITAL, ASPIRIN, AND CAFFEINE | 1 | 0.0058 |
| 3 | DAUNORUBICIN HYDROCHLORIDE | 9 | 0.0055 |
| 4 | BERACTANT | 2 | 0.0054 |
| 5 | OXYTOCIN | 13 | 0.0043 |
| 6 | ENALAPRILAT | 1 | 0.0039 |
| 7 | PORACTANT ALFA | 2 | 0.0027 |
| 8 | ECONAZOLE NITRATE | 2 | 0.0021 |
| 9 | HUMAN CYTOMEGALOVIRUS IMMUNE GLOBULIN | 1 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 42 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 21 |
| 2 | Protease Inhibitor [EPC] | 21 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 18 |
| 4 | Corticosteroid [EPC] | 17 |
| 5 | Polyene Antifungal [EPC] | 16 |
| 6 | Lipid-based Polyene Antifungal [EPC] | 15 |
| 7 | Benzodiazepine [EPC] | 14 |
| 8 | Penem Antibacterial [EPC] | 14 |
| 9 | Nitroimidazole Antimicrobial [EPC] | 13 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Oxytocic [EPC] | 13 | 0.0043 |
| 1 | Surfactant [EPC] | 3 | 0.0026 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 15 | 0.0012 |
| 3 | Methylating Agent [EPC] | 1 | 0.0010 |
| 4 | Protease Inhibitor [EPC] | 21 | 0.0005 |
| 5 | alpha-1 Adrenergic Agonist [EPC] | 2 | 0.0005 |
| 6 | Penem Antibacterial [EPC] | 14 | 0.0004 |
| 7 | Polyene Antifungal [EPC] | 16 | 0.0004 |
| 8 | Lipid Emulsion [EPC] | 1 | 0.0004 |
| 9 | Cytochrome P450 3A Inhibitor [EPC] | 21 | 0.0003 |